G8698 HCPCS — Reimbursement & Benchmarks

HCPCS Level II code G8698 documents that antithrombotic therapy was not prescribed at discharge and that no reason for the omission was recorded. This measure captures a gap in medication reconciliation and discharge planning for patients for whom antithrombotic therapy might otherwise be expected. Nationally, the code is relevant to quality reporting, transitions-of-care processes, and efforts to reduce preventable thrombotic events after hospitalization.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, common sites of service, and where the code is used in discharge documentation. The publication summarizes benchmarks and reporting implications associated with non-prescription of antithrombotic therapy, highlights potential policy and quality measurement connections, and outlines areas where billing and clinical documentation intersect.

This article is intended for a national audience of clinicians, coding professionals, and policy analysts seeking to understand the clinical meaning of G8698, how it fits into discharge medication workflows, and the implications for payer reporting and quality monitoring. Data not available in the input.

Billing Code Overview

HCPCS Level II code G8698 indicates antithrombotic therapy was not prescribed at discharge, reason not given. This code documents the absence of an antithrombotic prescription at the time of patient discharge when no reason for omission is recorded.

Service type: Medication reconciliation / discharge medication management
Typical site of service: Inpatient hospital discharge or other facility discharge where medications are reconciled

Data not available in the input.

Clinical Context

A typical patient is a 72-year-old male admitted with acute ischemic stroke who receives inpatient evaluation, stabilization, and discharge planning. During the hospitalization, stroke team clinicians evaluate indications for secondary stroke prevention including antithrombotic therapy. At discharge, the medication reconciliation and discharge instructions document that antithrombotic therapy was not prescribed, but no reason is recorded. Clinical workflow steps include inpatient neurology and hospitalist consultation, medication reconciliation by pharmacy, nursing discharge education, and placement of follow-up with primary care and neurology. The billing code G8698 is applied to reflect that antithrombotic therapy was not prescribed at discharge and the reason was not given in the chart.

Coding Specifications

Modifier	Description	When to Use
`24`	Unrelated evaluation and management service by the same physician during a postoperative period	Use when an unrelated E/M visit occurs during a global period that is not related to the inpatient procedure leading to discharge documentation.
`25`	Significant, separately identifiable evaluation and management service by the same physician on the same day of a procedure or other service

Taxonomy Code	Specialty	Notes
`2084P0800X`	Neurology	Neurologists lead stroke evaluation and secondary prevention decision-making.
`207RH0000X`	Internal Medicine	Hospitalists and internists manage inpatient care and medication reconciliation at discharge.
`293X00000X`	Clinical Pharmacy	Clinical pharmacists perform medication reconciliation and counseling for antithrombotic therapy.
`163WI0200X`	Hospitalist	Hospital medicine specialists coordinate discharge processes and documentation.
`207Q00000X`	Family Medicine	Primary care physicians manage post-discharge follow-up and long-term antithrombotic therapy decisions.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I63.9`	Cerebral infarction, unspecified	Representative of ischemic stroke for which antithrombotic therapy is typically considered at discharge.
`I63.50`	Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery, nondominant hemisphere	Indicates an ischemic event where secondary prevention with antithrombotic agents is commonly evaluated.
`I61.9`	Intracerebral hemorrhage, unspecified	Hemorrhagic stroke where antithrombotic therapy is often withheld; absence of a documented reason could trigger `G8698`.
`I67.89`	Other cerebrovascular diseases	Includes conditions that affect antithrombotic decision-making in discharge planning.
`G45.9`	Transient cerebral ischemic attack, unspecified	TIA patients commonly require antithrombotic therapy; documentation of omission is relevant.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99221`	Initial hospital care, typically 30-60 minutes	May be performed on admission for the inpatient evaluation that leads to discharge decisions about antithrombotic therapy.
`99238`	Hospital discharge day management, 30 minutes or less	Captures the discharge management encounter where antithrombotic prescriptions or their absence are documented.
`99495`	Transitional care management services with moderate complexity, face-to-face within 14 days	May be scheduled post-discharge to address medication management and follow-up when antithrombotic therapy was not prescribed.
`96372`	Therapeutic, prophylactic, or diagnostic injection (single) subcutaneous or intramuscular	Used when initiation of parenteral anticoagulation (e.g., enoxaparin) occurs prior to discharge in related workflows.
`90471`	Immunization administration (for single vaccine)	Occasionally performed during hospitalization for stroke patients as part of preventive care bundles accompanying discharge planning.

OpenPayer

Summary & Overview

HCPCS Level II G8698: Antithrombotic Therapy Not Prescribed at Discharge